Background: The contemporary health care environment is complex, with mounting pressures to perform greater procedural volumes with less support staff to minimize costs and to maximize efficiency. This report details an analysis of routine endovascular procedures performed in a hybrid operating room with dedicated vascular support staff during daytime hours compared with similar cases performed after hours with general operating room staff.
Background: The contemporary health care environment is complex, with mounting pressures to perform greater procedural volumes with less support staff to minimize costs and to maximize efficiency. This report details an analysis of routine endovascular procedures performed in a hybrid operating room with dedicated vascular support staff during daytime hours compared with similar cases performed after hours with general operating room staff.
Methods: All lower extremity endovascular cases during a 25-month period were identified by Current Procedural Terminology codes from a query of our institutional operating room database. Emergent/urgent cases and cases with associated open surgical procedures were excluded. Cases were divided by the time of day and available clinical support structure into two groups according to procedure start time: specialty-specific daytime (SS), with case starting between 7 AM and 3 PM weekdays; and general staff after hours (AH) for all others. The resulting case list was examined by case type according to SS or AH designation, and case types occurring disproportionately during either time frame were excluded to create the most similar case type distribution among the two groups for analytic purposes. Demographics, case specifics, and cost data were then obtained from the electronic health record and our enterprise cost data warehouse. Multivariable mixed linear modeling was used to examine component costs (eg, anesthesia, supplies) and total costs controlling for a number of factors that could affect cost.
Results: There were 275 routine endovascular-only procedures performed on 250 patients examined (203 SS, 47 AH). AH patients were younger, more likely to be female, and less likely to be taking antiplatelet agents at the time of the procedure than SS patients. Scheduled, elective cases made up 86% of SS cases and 55% of AH cases. No significant differences in procedure specifics were observed between the groups (number and location of access sites, type and number of interventions). Multivariable analyses controlled for factors affecting costs (including posting type, American Society of Anesthesiologists class, number of access sites, and interventional vs diagnostic case status). Costs associated with anesthesia (cost ratio, 1.85; P < .001), operating room supplies (cost ratio, 1.45; P ¼ .01), and postanesthesia recovery (cost ratio, 1.20; P ¼ .035) were all significantly increased in AH cases compared with SS cases. The average total hospital cost for routine endovascular cases performed AH was $9010 compared with $6143 for SS cases (cost ratio, 1.47; P < .001).
Conclusions: Performance of routine endovascular cases by specialtyspecific teams during regular hospital hours was associated with significantly less cost to the hospital system, with a w50% increase in total cost associated with AH cases. In the current health care environment, investments in specialty-specific teams and process improvements to facilitate case performance with these teams are likely to be cost-effective. Background: Subclavian artery revascularization is frequently performed in the setting of thoracic endovascular aortic repair (TEVAR) for a variety of indications ranging from prophylactic prevention of upper extremity and spinal cord ischemia to preservation of hemodialysis access or left internal mammary artery coronary artery bypass graft. Despite this, there is little information on the short-and long-term outcomes of patients undergoing carotid to subclavian artery bypass. We sought to define the outcomes associated with this procedure.
Methods: Patients undergoing carotid-subclavian bypass in conjunction with TEVAR between June 2005 and September 2016 were retrospectively identified from a prospectively maintained, single-center aortic surgery database. Categorical and continuous variables were compared using c 2 and Wilcoxon rank sum tests, respectively. The 30-day outcomes specific to the carotid-subclavian bypass procedure were analyzed, including nerve injury, bleeding complications, and local vascular complications. All preoperative and postoperative chest radiographs were carefully analyzed to assess for hemidiaphragm elevation indicative of phrenic nerve palsy. Long-term outcomes included primary graft patency and anastomotic complications.
Results: Of 579 patients undergoing TEVAR during this time interval, 114 patients (20%) underwent concomitant carotid-subclavian bypass. The cohort was 39% female (n ¼ 44), with a mean age of 65 6 14 years. The majority of conduits were 8-mm polytetrafluoroethylene grafts (n ¼ 107 [92.2%]), with a minority being reversed saphenous vein grafts (n ¼ 4 [3.5%]). The bypass procedure was done concomitantly at the time of TEVAR in 90.4% (n ¼ 103) of cases. The short-term complication rate attributed specifically to the carotid-subclavian bypass was 21% (n ¼ 24). These complications included neck hematoma requiring re-exploration in 0.9% (n ¼ 1), recurrent laryngeal nerve palsy in 5.3% (n ¼ 6), axillary nerve palsy in 1.8% (n ¼ 2), and phrenic nerve palsy in 13.2% (n ¼ 15) of patients. The 30-day all-cause mortality rate was 5.3% (n ¼ 6), and the rate of permanent paraparesis or paraplegia was 0.9% (n ¼ 1). Of the operative survivors (n ¼ 108), follow-up imaging of the bypass graft was available in 84% (n ¼ 96) of patients. Actuarial primary graft patency was 97% at 10 years (Fig) . There were three patients (2.5%) with bypass graft occlusions, two of which were clinically silent and detected in follow-up imaging. The third was detected because of the symptoms of subclavian steal and required repeated revascularization. Two patients (1.8%) developed a late anastomotic pseudoaneurysm requiring either endovascular (n ¼ 1) or surgical (n ¼ 1) intervention.
Conclusions: Carotid-subclavian bypass for revascularization of the subclavian artery performed in the setting of TEVAR is durable, although the true complication rate is likely to be higher than generally reported in the literature because of a not insignificant rate of phrenic nerve palsy. These data should serve well as "gold standard" comparison data for emerging branch graft devices. Background: We proposed to assess the gender-based differences in age, body mass index (BMI), race, comorbidities, abdominal aortic Abstracts
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